KDR c.2959G>C ;(p.E987Q)

Variant ID: 4-55960981-C-G

NM_002253.2(KDR):c.2959G>C;(p.E987Q)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Phase II Study of Lenvatinib in Patients With Progressive, Recurrent or Metastatic Adenoid Cystic Carcinoma.

Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology
Tchekmedyian, Vatche V; Sherman, Eric J EJ; Dunn, Lara L; Tran, Crystal C; Baxi, Shrujal S; Katabi, Nora N; Antonescu, Cristina R CR; Ostrovnaya, Irina I; Haque, Sofia S SS; Pfister, David G DG; Ho, Alan L AL
Publication Date: 2019-06-20

Variant appearance in text: VEGFR: E987Q
PubMed Link: 30939095
Variant Present in the following documents:
  • Main text
View BVdb publication page